Full text
PDFPage 1313
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Gibson A. C. Depot injections and tardive dyskinesia. Br J Psychiatry. 1978 Oct;133:361–365. doi: 10.1192/bjp.133.4.361. [DOI] [PubMed] [Google Scholar]
- Paulson G. W. Tardive dyskinesia. N Y State J Med. 1979 Feb;79(2):193–195. [PubMed] [Google Scholar]
- STOLZE R., ULE G. Die Bedeutung der Trigeminusdegeneration für die Sprachstörung bei der hereditären Ataxie. Nervenarzt. 1957 Jan 20;28(1):35–36. [PubMed] [Google Scholar]
- Shopsin B., Klein H., Aaronsom M., Collora M. Clozapine, chlorpromazine, and placebo in newly hospitalized, acutely schizophrenic patients: a controlled, double-blind comparison. Arch Gen Psychiatry. 1979 Jun;36(6):657–664. doi: 10.1001/archpsyc.1979.01780060047005. [DOI] [PubMed] [Google Scholar]
- Tamminga C. A., Crayton J. W., Chase T. N. Improvement in tardive dyskinesia after muscimol therapy. Arch Gen Psychiatry. 1979 May;36(5):595–598. doi: 10.1001/archpsyc.1979.01780050105013. [DOI] [PubMed] [Google Scholar]
- Wegner J. T., Struve F. A., Kantor J. S., Kane J. M. Relationship between the B-mitten EEG pattern and tardive dyskinesia. A pilot control study. Arch Gen Psychiatry. 1979 May;36(5):599–603. doi: 10.1001/archpsyc.1979.01780050109016. [DOI] [PubMed] [Google Scholar]